GE HealthCare Technologies (GEHC) Earnings Analysis

GE HealthCare Technologies (GEHC) next reports earnings on 2026-07-29, consensus EPS 1.04 USD. Last quarter (2026-04-29) it missed with EPS 0.99 USD vs 1.04 USD est (-4.8%). It has beaten estimates in 4/5 recent quarters (80%). Trailing P/E 18.61.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does GEHC next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate1.04 USD
Revenue estimate5.26B

GEHC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.99 USD1.04 USD-4.8%Miss
2026-02-041.44 USD1.4 USD+2.9%Beat
2025-10-291.07 USD1.05 USD+1.9%Beat
2025-04-301.01 USD0.914 USD+10.5%Beat
2025-02-131.45 USD1.26 USD+15.1%Beat

Beat rate: 4/5 (80%) over reported quarters with consensus data.

GEHC valuation and analyst view

Trailing P/E18.61
Trailing EPS3.3 USD
Price / book2.62
Dividend yield0.23%
Market cap28.03B
Analyst consensusBuy (10 buy / 8 hold / 0 sell)
Avg price target74.9 USD

Related research pages

Frequently asked questions

When is GE HealthCare Technologies (GEHC)'s next earnings date?

GE HealthCare Technologies is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 1.04 USD and revenue estimate of 5.26B.

Did GEHC beat earnings last quarter?

In its 2026-04-29 report, GEHC posted EPS of 0.99 USD versus a 1.04 USD estimate — a miss of 4.8%.

What is GEHC's earnings track record?

Over the last 5 reported quarters with consensus data, GEHC beat estimates 4 times (80%).

What is GEHC's current P/E ratio and EPS?

GEHC trades at a trailing P/E of 18.61 on trailing EPS of 3.300438596491228 USD.

What do analysts rate GEHC?

Analyst consensus is "Buy" across 18 ratings (0 strong buy, 10 buy, 8 hold, 0 sell, 0 strong sell). Average 12-month price target: 74.9 USD.